| Authors: |
Filippini DM; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, Università di Bologna, Bologna, Italy., Cabarrou B; University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Biostatistics & Health Data Science Unit, Toulouse, France., Dupain C; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France., Halladjian M; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France., Coquan E; Department of Medical Oncology, Centre Francois Baclesse, Caen, Cedex, France., Sablin MP; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France., Mazzarella L; Laboratory of Translational Oncology, European Institute of Oncology IRCCS, Milan, Italy., Francisco M; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Servant N; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Tonini MM; Translational Medicine Operations Hub, Luxembourg Institute of Health, Luxembourg., Hundt AF; Translational Medicine Operations Hub, Luxembourg Institute of Health, Luxembourg., Castel-Ajgal Z; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France., You B; Department of Medical Oncology, Hospices de Lyon, Lyon, France., Bigot F; Institut de Cancérologie de l'Ouest, Angers, France., Ghiringhelli F; Centre Georges-François Leclerc, Dijon, France., Vansteene D; Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Gomez-Roca C; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Cousin S; Institut Bergonié, Bordeaux, France., Lambert A; Institut de Cancérologie de Lorraine, Vandœuvre-Lès-Nancy, France., Saada-Bouzid E; Centre Antoine Lacassagne, Nice, France., Durando X; Centre Jean Perrin, Clermont-Ferrand, France., Abdeddaim C; Centre Oscar Lambert, Lille, France., Borel C; Department of Medical Oncology, ICANS, Strasbourg, France., Chaltiel R; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Borcoman E; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France., Legrand F; R&D Department, Unicancer, Paris, France., Bernhart S; IZBI, Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Leipzig, Germany., Jimenez M; R&D Department, Unicancer, Paris, France., Bièche I; Department of Genetics, Institut Curie, Paris, France., Filleron T; University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Biostatistics & Health Data Science Unit, Toulouse, France., Le Tourneau C; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France; Paris-Saclay University, Paris, France., Kamal M; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France., Jeannot E; Department of Genetics, Institut Curie, Paris, France; Department of Pathology, Institut Curie, Paris, France. Electronic address: emmanuelle.jeannot@curie.fr. |
